Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 8873 - 8880 of 11456 results
Failure to Obtain Required Retailer Approval Scuttles Target-MasterCard Data Breach Settlement
May 26, 2015| Blog| Viewpoint
REMINDER: Webinar - The Long Reach of COPPA
May 26, 2015| Blog| Viewpoint
The NAI Issues Privacy Guidelines For Interest-Based Advertising, Ad Delivery and Reporting
May 22, 2015| Blog| Viewpoint
FDA Makes More Electronic Submissions Mandatory
May 22, 2015| Blog| Viewpoint
USCIS Releases Guidance and Frequently Asked Questions for H-4 Employment Authorization Applications
May 22, 2015| Advisory| Viewpoint
Nation’s Wind Power Potential Assessed in DOE Report
May 21, 2015| Blog| Viewpoint
Duty to Monitor Investments Extends Statute of Limitations for Fiduciary Breach Claim Says Supreme Court
May 20, 2015| Blog| Viewpoint
ML Strategies: 21st Century Cures and Other Health Legislation Markup
May 20, 2015| Blog| Viewpoint
News & Press Releases
Mintz is pleased to announce that 31 attorneys have been named Massachusetts Super Lawyers and 35 attorneys have been named Massachusetts Rising Stars for 2024.
Mintz IP Group Named “Litigation Department of the Year” in 2024 New England Legal Awards
October 02, 2024
Mintz’s intellectual property litigation group was named “Litigation Department of the Year” for the IP specialty category in the 2024 New England Legal Awards. The awards recognize attorneys and firms in Connecticut, Maine, Vermont, New Hampshire, Massachusetts, and Rhode Island.
Defending AI, Machine Learning Patents In Life Sciences
October 1, 2024
Intellectual Property Chair Michael Renaud and Associates Meena Seralathan, Simone Yhap, and Williams Dixon recently wrote an article for Law360 focused on protecting artificial intelligence and machine learning patents in the life sciences industry following the US Supreme Court’s 2014 decision in Alice v. CLS Bank.